Introduction
Natural products have been used in medicine since ancient times, and especially in the past 70 years they have served us well as anti-infective, anticancer and other therapeutics. [1, 2] Despite their great benefitt oh uman health it is mostly unknown Simple urea compounds ("phurealipids") have been identified from the entomopathogenicb acterium Photorhabdusl uminescens,a nd their biosynthesis wase lucidated. Very similara nalogues of thesec ompounds have been previously developed as inhibitors of juvenile hormonee poxide hydrolase (JHEH),a key enzyme in insect development and growth. Phurealipids also inhibit JHEH, and therefore phurealipids might contribute to bacterial virulence. why nature has developed these compounds and what their biological roles are, [3, 4] although examples of natural products acting as virulence factors, [5] signalling molecules [6] and antimicrobials [7] are known.E ntomopathogenic bacteria of the genus Photorhabdus live in symbiosis with nematodeso ft he genus Heterorhabditis,a nd together they are ablet oi nfect and kill insect larvae. Probably because of the complex bacterial interactions with the nematode host and the insect prey (communication within the bacterial community and between bacteria and nematodes, virulence against the insect prey,d efence against food competitors)t hese bacteria are producers of several naturalp roducts.
Here, we describe urea lipid compounds,w hichw en ame "phurealipids" (Photorhabdus urea lipids) produced by the insect pathogen Photorhabdusl uminescens to inhibit juvenile hormonee poxide hydrolase (JHEH), ak ey enzyme in insect development and growth;s imilar compounds have been developed chemically as insecticides.
Results and Discussion
Ad etailed HPLC/MS analysiso fP. luminescens TTO1 showed the presence of four compounds (1-4)w ith m/z between 215 and 257 [M+ +H] + (TableS1i nt he Supporting Information). The molecular formulae of 1, 3 and 4 as determined by HR-ESI-MS (Table S1 )i na ddition to their mass fragmentation patterns indicatede ither ag lycine amide or au rea-deriveds tructure;t he loss of 57 Da is characteristic for either ag lycine or am ethyl urea moiety (Figure 1 ). The structure and nature of the alkyl side chains were confirmed by labellinge xperiments( Ta ble S1). Briefly, 1-3 were labelledw ith fully deuterated leucine, thereby indicating the presence of al eucine-derived iso-branched fatty acid;n ol abellingw as observedw ith deuterated valine (indicative of iso even branched amines) or propionic acid (indicative of unevenl inear amines)f or any compound. Al inear,e vennumbered side chain similart ot hat from standard fatty-acid biosynthesis was assumed for 4.C ompounds 1, 3 and 4 showedt he expected labelling with deuterated l-[methyl-2 H 3 ]-methionine exclusively at the polar moietya nd not the side chain (where it could also occur following the biosynthesis of methylated fatty acids), thus confirming am ethyl urea moiety (Table S1 ). This was subsequently provenb yc hemical synthesis of both glycinea mide and the methyl urea derivativeo f4 (identical t R valuesf or synthetic and natural 4). Compound 2 showedaneutralloss of 43 Da, corresponding to the desmethyl derivative of 1 (Figure 2) .
Based on the structures of the identified phurealipids (Scheme 1), ab iosynthetic pathway was postulated starting from different fatty-acid-derived aldehydes, which are subsequently transformed into the corresponding amines, carbamoylated and finally methylated (Scheme 2). Twoc arbamoyltransferases were identified in the genome of the producing strain. Gene disruption by plasmid integration( Figure S1 in the Supporting Information) into one of them, plu2076 (here renamed pliA (phurealipid)), led to complete loss of phurealipid production.D isruption of the second carbamoyltransferase, plu4565,d id not affect phurealipid biosynthesis, although these mutants were no longera ble to produce av irulence factor that we termed "Photorhabdus clumping factor"o r "PCF", [8] the structure of whichi sc urrently unknown. Despite the fact that more than 15 methyltransferase homologues were identified in the P. luminescens genome, comparative genome analysis between different Photorhabdus and Xenorhabdus strains revealed only plu2237 to be unique to P. luminescens (the only phurealipid producer with as equenced genome). [9] Subsequentg ened isruption ( Figure S1 ) of plu2237 (whichw er enamed pliB)l ed to the biosynthesis of ad ifferent www.chembiochem.org phurealipid profile. Detailed MS and labellinge xperiments revealed the presence of desmethylphurealipids B( 5)a nd C( 6; Figure 1 , Ta ble S1), whose structures were confirmed by synthesis. As earch for additional phurealipid-producing strains in our entomopathogenicb acteria strain collection [10] based on HPLC/MS analysis of over 250 strainsr evealed 1 to be widespread in P. luminescens strains (Figure 3, FigureS2) but very rare in Photorhabdus asymbiotica or Photorhabdus temperata, consistentw ith the fact that no plu2076 homologue could be found in the genome of P. asymbiotica. [11] However,t hree Xenorhabdus strains isolated in Vietnam and related to Xenorhabdus ehlersii DSM 16337 showed production of 1 ( Figure S3) .
In independent research, closely related synthetic compounds have been previously described as inhibitors of insect juvenile hormone epoxide hydrolase (JHEH). [12] [13] [14] In conjunction with juvenile hormonee sterase (JHE), JHEH is ak ey player in the degradation of juvenile hormone (JH), which regulates both growth andd evelopment of insect larvae and reproductive functions of adults, [15] and is also produced by the plant Cyperiusi ria as ad efence mechanism against insects. [16] Importantly, P. luminescens phurealipids and the related synthetic insecticides are structurally similar to JH (Scheme 2), thus suggesting ap ossible mode of action. We tested all phurealipids against JHEH purified from caterpillars of the tobacco hornworm Manduca sexta and demonstrated that 1, 3 and 4 showed IC 50 values of 6.5 AE 0.9, 30 AE 4, and 10.7 AE 1.2 mm,r espectively.These are in as imilar range to that observed for the known synthetic inhibitor 13 (Scheme1,T able S2;I C 50 = 2.3 AE 0.6 mm)a nd is in agreement with comparable K I values (1.80 AE 0.30 and 0.35 AE 0.04 mm for 1 and 13,r espectively;F igureS4). Although desmethylphurealipid B( 5)s howedw eak activity against JHE( IC 50 = 25 AE 4 mm), no other derivatives showeda ctivity (> 100 mm)a gainst either JHE or JHEH (Table S2) .
Upon infectiono fGalleria mellonella larvae, P. luminescens produced phurealipids at up to 200 mm ( % 44 mg L À1 ;F igure S5) as determined by HPLC/MS. This would be sufficient to inhibit JHEH and thus might lead to an increaseinJ H. JH accu- Scheme1.Natural phurealipids 1-6 and synthetic derivatives 7-13.
Scheme2.Proposed biosynthesis of phurealipid A( 1), and structureo fJ HIII.
ChemBioChem 2015, 16,766 -771 www.chembiochem.org mulationi nDrosophila melanogaster inhibits the production of antimicrobial peptides (AMPs), thusi ndicating that JH acts as ah umoral immuno-suppressor. [17] Hence, manipulation of JH levels influences not only insect development but also the efficacy of the immune response. Ta ken together,t hese data suggest that phurealipids contribute to the overall virulence of P. luminescens by inhibiting JHEH activity and therefore limiting AMP production.
To test this hypothesis, we used quantitative reverse-transcriptaseP CR to measure the RNA levels of certain AMP genes (lysozyme, gallerimycin,m oricina nd cecropin)i nc aterpillars of M. sexta and the greater waxmoth G. mellonella challenged with Serratia entomophila or Salmonella enterica,r espectively, following injection of different ureal ipid compounds (Figure S6) . The known synthetic inhibitor 13 demonstrated the best activity (lower levels of AMP RNAs relative to the control). Of the natural compounds, desmethylphurealipid A( 2)w as the most activei nt his assayb ut showed no JHEH inhibitory activity in vitro, thus suggestingo ther or additional JHEH independent activitiesf or phurealipids in vivo.
We also tested whether urea lipids predicted to lead to JH III accumulation by JHEH inhibition influence the embryonic development of the emerging insect model organism Tribolium castaneum.A sm ethoprene was described [18] as aJ HIII mimic used as insecticide, it was used as positive control for 13 (the mosta ctive urea compound inhibiting JHEH).A ll T. castaneum embryos treated with methoprene proceeded through gastrulation, germ band elongation and germ band retraction normally,b ut failed to internalise the remaining yolk sac during dorsal closure ( Figure S7 ;S upporting Movie 1). The result was significant compared to the PBS and DMSO controls ( Figure S7 c) , thus confirming the insecticidal effect of this compound. [19, 20] In contrast, embryost reated with 13 were able to proceedt hrough dorsal closure normally ( Figure S7 , Supporting Movie 1), and the percentage of embryos successfully completing development didn ot differ significantly from those subjected to PBS and DMSO ( Figure S7 ).
JH has been reported to influenceg ene expression in protozoan termite gut symbionts [21] and to play ar ole in Ca 2 + homeostasis, [22] in addition to exertinge pigenetic control of gene expression. [23] Based on their structuralr esemblances,s imilar activities might be exist for phurealipids. Indeed, the desmethyl urea lipids in particular exhibited very strong activity against Leishmania donovani and were in fact at least 10 times more active than the methylated derivatives (Table S2) . L. donovani, the causative agent of leishmaniasis( kala-azar), is not known to employa ny JH-like regulatory pathways, but the promising activity of such simple compounds will be studied in more Figure 3 . Phylogenetic tree basedo na646 bp region of recA (encoding the highly conserved RecA proteini nvolved in DNA repair) for different Photorhabdus strains (outgroup: E. coli).
[34] The tree was reconstructed by the maximum likelihood approach (ClustalWalignment). Jukes-Cantor (JC69)w as used as substitution-model;bootstrap values are basedo n1 000 replicates. Right:relative productiono fp hurealipids 1-6.A ll strains were analysed by HPLC/MS; mostly strainso fP. luminescens produce phurealipids, as identified by retention time and MS/MSd ata. www.chembiochem.org detail in the future. Furtherb ioactivity tests revealed neither antibacterial nor antifungal activity for any phurealipid,a nd althougho ther urea derivatives are quorum quenching compounds in Gram-negative bacteria, [24] no such activity was observed forp hurealipids.I ne xperimental infections of the caterpillar M. sexta,n od ifferencei nv irulence was observed between the pliA insertion mutant and the parental wild-type strain. Nevertheless,b ecause of the large redundancy of virulence factors in this bacterium it is likely that the contribution of the phurealipids to the overall virulence is masked. Precedence for this can be seen in the observation that strains lacking the highly potent Mcf1 toxin remaina sv irulenta st he wild type, [25] and disruption of rhabdopeptide biosynthesis in the related bacterium Xenorhabdus nematophila had only as light effect on overall toxicity whereas the pure compounds showed insecticidal activity. [26] Moreover,i th as been proposed that the "stacking" of multiple virulence factors gives P. luminescens a selectivea dvantage during typical suboptimal infection scenarios and in diverse hosts in nature. [25] It is interesting that P. luminescens produces as mall library of phurealipids in similara mounts, as has been observed for other compound classes, such as rhabdopeptides,x entrivalpeptides and taxlllaids. [26] [27] [28] Because the nematode vector shows little insect host specificity, [29] we propose that this might provide P. luminescens with the ability to inhibitd iverse JHEHs from ar ange of insect orders. JHs differing in the presence of methyl or ethyl substituents, degree of saturation and epoxidem oietiesh ave been described from different insects, thus making the presence of slightly different JHEHs quite likely. [30] The phurealipids offer ar aree xample of ac ompound class originally developed by synthetic chemists to address aspecific molecular target,b ut which had in fact already been "developed" by P. luminescens much earlier.W ec an draw parallels with the cultivation and use of antifungal-producing Streptomyces by leaf-cutting ants [31, 32] or bark beetles [33] to protect their fungal gardens against pathogenic fungi, similart o humans using such compounds in antifungal therapy.T hese examples clearly highlightt he value of organismsp roducing natural product, both as sources of molecules and as inspiration for much-needed novel bioactive compounds.
